KalVista Pharmaceuticals to Present at Healthcare Conference

Got story updates? Submit your updates here. ›

KalVista Pharmaceuticals, a biopharmaceutical company focused on developing novel treatments for diabetic macular edema and other serious diseases, announced that it will present at the 25th Annual Needham Virtual Healthcare Conference on April 8, 2026.

Why it matters

As a leading biotech company, KalVista's participation in this high-profile industry conference signals its continued progress in advancing its pipeline of innovative therapies. The presentation will provide investors and analysts an opportunity to learn more about the company's latest developments and future plans.

The details

During the conference, KalVista executives will share updates on the company's clinical programs and strategic initiatives. The presentation will cover the company's efforts to develop novel treatments for diabetic macular edema and other serious conditions.

• KalVista Pharmaceuticals will present at the 25th Annual Needham Virtual Healthcare Conference on April 8, 2026.

What’s next

Investors and analysts will be able to access KalVista's presentation and participate in a Q&A session during the virtual conference.